(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Pivotal Research Centers is conducting a research study with an investigational medication for overactive bladders in women.
Eligible candidates should be women ages 18-65 who urinate more than eight times in a 24-hour period.
Participants will receive at no cost a study-related drug and physical and will be compensated for their time and travel.
The research site is in Peoria, Ariz.
Please see http://www.centerwatch.com/patient/studies/cat195.html.
This study is designed to establish the safety and tolerability of a single dose of MDX-1100 in patients with ulcerative colitis.
Successful canndidates should be 18 years or older with active ulcerative colitis and a DAI no less than 4 and no greater than 9. They should not have a history of colectomy, partial colectomy, current ostomy, or pouchitis. Other criteria also apply.
The research site is in Los Angeles.
Please see http://www.centerwatch.com/patient/studies/cat152.html.
This is a research study of an approved oral medication for Erectile dysfunction (ED).
Gay men who are experiencing ED may qualify, if they are in a stable relationship with one male partner.
Study-related care and medication will be provided at no charge to qualified volunteers.
The research site is in Houston, Tex.
Please see http://www.centerwatch.com/patient/studies/cat371.html.
Copyright 2006 CenterWatch.
All rights reserved.